Onco-Innovations Limited (CVE:ONCO) | WebDisclosure

Basculer en Français

10812	Companies
234240	Keywords
163037	Articles
125255	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

PRESS RELEASE

published on 06/20/2026 at 00:00, 1 month 18 days ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Onco-Innovations completes successful 300g scale-up batch of A83B4C63, achieving 99.3% purity for API under ONC010 PNKP Inhibitor Technology. Dave Antony appointed as CFO

CFO Manufacturing Milestone Onco-Innovations Dave Antony Scale-up Batch
BRIEF

published on 06/17/2026 at 00:05, 1 month 21 days ago

Onco-Innovations et Kuano finalisent un projet de collaboration sur la technologie des inhibiteurs de PNKP

Découverte De Médicaments Onco-Innovations Inhibiteur De PNKP Plateforme Quantique Découverte Facilitée Par L'IA
BRIEF

published on 06/17/2026 at 00:05, 1 month 21 days ago

Onco-Innovations and Kuano Complete Collaborative Project on PNKP Inhibitor Technology

Drug Discovery Onco-Innovations PNKP Inhibitor Quantum-based Platform AI-enabled Discovery
PRESS RELEASE

published on 06/17/2026 at 00:00, 1 month 21 days ago

Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization
Onco-Innovations announces successful completion of a pilot project with Kuano Ltd., advancing its PNKP Inhibitor Technology through AI and quantum-based computational approaches

AI-enabled Onco-Innovations Kuano Ltd. PNKP Inhibitor Technology Quantum-based
BRIEF

published on 06/10/2026 at 00:05, 1 month 28 days ago

Onco-Innovations Advances PNKP Inhibitor Technology Scaling

Clinical Trials Cancer Treatment Pharmaceutical Manufacturing Onco-Innovations API Development
BRIEF

published on 06/10/2026 at 00:05, 1 month 28 days ago

Onco-Innovations fait progresser la mise à l'échelle de la technologie des inhibiteurs de PNKP

Essais Cliniques Traitement Du Cancer Fabrication Pharmaceutique Onco-Innovations Développement D'API
PRESS RELEASE

published on 06/10/2026 at 00:00, 1 month 28 days ago

Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology
Onco-Innovations starts process development & scale-up activities for A83B4C63, advancing towards clinical trials. Collaboration with Dalton Pharma Services to optimize production processes and ensure regulatory readiness

Clinical Trials API Onco-Innovations Dalton Pharma Services Process Development
BRIEF

published on 06/06/2026 at 00:05, 2 months 2 days ago

Onco-Innovations and Nanosoft Polymers Collaborate on Drug Delivery Development

Drug Delivery Onco-Innovations Nanosoft Polymers ONC010 Program Polymer Development
BRIEF

published on 06/06/2026 at 00:05, 2 months 2 days ago

Onco-Innovations et Nanosoft Polymers collaborent au développement de systèmes d'administration de médicaments

Administration De Médicaments Onco-Innovations Nanopolymères Souples Programme ONC010 Développement Des Polymères
PRESS RELEASE

published on 06/06/2026 at 00:00, 2 months 2 days ago

Onco-Innovations Signs LOI with Nanosoft Polymers to Advance Polymer and Drug Delivery Development for the ONC010 Program
Onco-Innovations partners with Nanosoft Polymers for polymer process and drug formulation optimization activities. Appointment of Dave Antony as VP Corporate Finance announced

Onco-Innovations Nanosoft Polymers Polymer Process Drug Formulation Optimization Dave Antony

Accesswire

Published on 08/08/2026 at 00:00, 13 hours 45 minutes ago

Boron One Announces Change of Auditor
Published on 08/07/2026 at 23:15, 14 hours 30 minutes ago

Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 14 hours 45 minutes ago

Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 15 hours 15 minutes ago

UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 15 hours 30 minutes ago

Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services

View all ACCESSWIRE

EQS Group

Published on 08/07/2026 at 23:21, 14 hours 24 minutes ago

EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 18 hours 15 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 18 hours 30 minutes ago

ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 19 hours 35 minutes ago

Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:00, 19 hours 45 minutes ago

E-PANGO: Composition du capital au 31 juillet 2026

Les Echos

Published on 08/07/2026 at 18:54, 18 hours 51 minutes ago

Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 18 hours 51 minutes ago

Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 19 hours 5 minutes ago

Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 19 hours 5 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 19 hours 45 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026

View all LES ECHOS COMFI WIRE